Alan Dunton

Alan Dunton

Director/Board Member at CORMEDIX INC.

Net worth: 595 501 $ as of 2026-05-30

71 year
Health Technology
Consumer Services
Commercial Services

Profile

Dr. Alan W.
Dunton
, MD, is an Independent Non-Executive Director at Recce Pharmaceuticals Ltd., an Independent Director at CorMedix, Inc., an Independent Director at Palatin Technologies, Inc. and an Independent Director at Oragenics, Inc. He is on the Board of Directors at Recce Pharmaceuticals Ltd., CorMedix, Inc., Cytogel Pharma LLC, Palatin Technologies, Inc., Oragenics, Inc. and ActivBiotics, Inc. Dr. Dunton was previously employed as an Independent Non-Executive Director by Regeneus Ltd., a SVP-Regulatory Affairs, Research & Development by Purdue Pharma LP, a Non-Executive Director by Bionomics Ltd., a Chief Medical Officer by Derma Sciences, Inc., a Non-Executive Chairman by EpiCept Corp., a Chief Medical Officer by Marina Biotech, Inc., a Managing Director by Panacos Pharmaceuticals, Inc., an Independent Director by Targacept, Inc., a Principal Owner by Danerius LLC, a President & Chief Executive Officer by Metaphore Pharmaceuticals, Inc., a President, Chief Operating Officer & Director by Emisphere Technologies, Inc., a President & Managing Director by The Janssen Research Foundation, a Senior Executive by Johnson & Johnson, a Vice President-Clinical Research & Development by Syntex Corp., a Vice President-Clinical Research & Development by Ciba-Geigy Corp., a Vice President-Clinical Research & Development by Hoffmann-La Roche, Inc., a Chairman by Janssen-Cilag International NV, He received his undergraduate degree from State University of New York at Buffalo and a doctorate degree from New York University School of Medicine.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2026-04-12 40,250 ( 0.05% ) 339 710 $ 2026-05-30
2025-12-08 14,081 ( 0.79% ) 197 416 $ 2026-05-30
2025-06-29 146,288 ( 0.05% ) 57 889 $ 2026-05-30
2026-04-29 802 ( 0.02% ) 486 $ 2026-05-30

Alan Dunton active positions

CompaniesPositionStart
CORMEDIX INC. Director/Board Member 2019-02-28
ORAGENICS, INC. Director/Board Member 2011-03-31
PALATIN TECHNOLOGIES, INC. Director/Board Member 2011-06-21
RECCE PHARMACEUTICALS LTD Director/Board Member 2020-07-13
Director/Board Member 2018-09-30
Director/Board Member 2006-12-31

Former positions of Alan Dunton

CompaniesPositionEnd
REGENEUS LTD Director/Board Member 2021-02-24
Chief Tech/Sci/R&D Officer 2018-02-28
ADHERA THERAPEUTICS, INC. Chief Tech/Sci/R&D Officer 2017-02-20
░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░ ░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
See the detail of Alan Dunton's experience

Training of Alan Dunton

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

71

1st degree connections

34

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies34

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Distribution Services

Health Technology

Retail Trade

Consumer Services

Health Technology

Health Technology

Health Technology

The Janssen Research Foundation

R.W. Johnson Pharmaceutical Research Institute

Danerius LLC

Commercial Services

Johnson & Johnson Pharmaceutical Group

Health Technology

Health Technology

Consumer Services

Commercial Services

Health Technology

Health Technology

- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!